Entering text into the input field will update the search result below

Premarket analyst action - healthcare

Oct. 15, 2018 7:30 AM ETargenx SE (ARGX) StockLLY, ABUS, TLPH, ZTS, KALV, ARGX, ELANBy: Douglas W. House, SA News Editor
  • Argenx (NASDAQ:ARGX) initiated with Outperform rating and $110 (51% upside) price target at Evercore ISI.
  • Elanco Animal Health (NYSE:ELAN) initiated with Equal Weight rating at Morgan Stanley. Initiated with Overweight rating and $38 (17% upside) price target at JPMorgan. Initiated with Buy rating and $37 price target at Citigroup. Initiated with Neutral rating and $30 price target at Goldman Sachs. Initiated with Outperform rating and $38 price target at Cowen and Company.
  • KalVista Pharmaceuticals (NASDAQ:KALV) initiated with Buy rating and $33 (76% upside) price target at Stifel.
  • Eli Lilly (NYSE:LLY) resumed with Neutral rating and $120 (9% upside) price target at Goldman.
  • Arbutus Biopharma (NASDAQ:ABUS) upgraded to Neutral with a $5 (16% upside) price target at Wedbush. Sharses up 2% premarket.
  • AcelRx Pharmaceuticals (NASDAQ:ACRX) upgraded to Buy with an $8 (101% upside) price target at Jefferies after the Ad Com nod for DSUVIA. Shares up 26% premarket.
  • Zoetis (NYSE:ZTS) upgraded to Overweight with a $100 (12% upside) price target at JPMorgan.

Recommended For You

More Trending News

About ARGX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ARGX--
argenx SE